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light or moderate to vigorous physical
activity modulate inflammatory status in
adults?
Catherine M. Phillips1,2*, Christina B. Dillon1 and Ivan J. Perry1
Abstract
Background: Sedentary behaviour, obesity and insulin resistance are associated with pro-inflammatory status. Limited
data on whether physical activity modulates inflammatory status and counteracts obesity and insulin resistance
associated low-grade inflammation exist. Our objective was to investigate associations between objectively measured
physical activity and inflammatory status, and specifically whether substituting daily sedentary behaviour with light
activity or moderate to vigorous physical activity (MVPA), is associated with beneficial alterations to the inflammatory
profile among middle-aged adults and those at increased cardiometabolic risk (obese and insulin resistant subjects).
Methods: Data are from a sub-sample of the Mitchelstown cohort; a population-based cross-sectional sample of 2047
Irish adults. Physical activity intensity and duration were measured in 396 participants for 7-consecutive days using the
GENEActiv accelerometer. Isotemporal regression analysis examined the associations between replacing 30 min per
day of sedentary behaviour with equal amounts of light activity and MVPA on inflammatory factors (serum acute-phase
reactants, adipocytokines, pro-inflammatory cytokines and white blood cells (WBC)).
Results: Reallocating 30 min of sedentary time with MVPA was associated with a more favourable inflammatory profile
characterized by higher adiponectin and lower complement component C3 (C3), leptin, interleukin 6 (IL-6) and WBC
concentrations (P < 0.05). No significant effects were noted with substitution of sedentary time with light activity.
Among the obese subjects replacing sedentary behaviour with an equivalent amount of MVPA was associated with
lower WBC counts (P < 0.05); no associations were detected among the insulin resistant (HOMA-IR >75th percentile)
subjects. Among the non-obese and non-insulin resistant subjects substituting 30 min of sedentary behaviour with
MVPA was associated with decreased C3, IL-6 and WBC concentrations.
Conclusions: Replacing sedentary behaviour with MVPA modulates pro-inflammatory status. These findings, which
highlight the need for the developing randomized trials aimed at lowering cardiometabolic risk, warrant further investigation.
Keywords: Physical activity, Inflammation, Obesity, Insulin resistance, Complement component C3, Moderate to vigorous
physical activity, Pro-inflammatory cytokines, Adipocytokines
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Background
Sedentary behaviour increases risk of obesity, type 2 dia-
betes (T2DM), cardiovascular disease (CVD), cancer,
and shortens life expectancy [1–3]. Conversely physical
activity exerts beneficial health effects including de-
creased risk of these conditions and reduced all-cause
mortality [4–6]. Multi-factorial mechanisms, including
the anti-inflammatory and insulin sensitising effects of
physical activity and exercise, underlie the positive asso-
ciations with cardiometabolic outcomes [7–10]. How-
ever, the supporting evidence is largely based on a
limited range of inflammatory markers and self-reported
physical activity. Objective and subjective methods, such as
accelerometers and questionnaires, are currently the most
commonly used methods to measure physical activity. Self-
reported data are subject to recall and reporting biases, and
poor agreement between objective and subjective measures
of physical activity has been reported [11, 12]. Indeed the
conflicting associations between self-reported and acceler-
ometer based MVPA and CRP levels from the National
Health and Nutrition Examination Survey (NHANES)
underscore this issue [13, 14].
Insulin resistance and obesity are characterized by a
low-grade but chronic inflammatory state [15]. We have
recently shown that having a favourable inflammatory sta-
tus [16] and a moderate to high level of physical activity
[17] are both independently and positively associated with
metabolic health status among obese middle-aged adults.
Data on potential modulation of inflammatory status by
physical activity in individuals with increased cardiometa-
bolic risk are scarce. Data from the NHANES demon-
strated an inverse association between objectively
measured MVPA and CRP levels among diabetic adults
[13]. The ATTICA study evaluated the relationship be-
tween self-reported leisure time physical activity and in-
flammatory markers in adults with metabolic syndrome
(MetS) [18]. Relative to the sedentary MetS individuals
those who were physically active had lower CRP, IL-6,
tumour necrosis factor α (TNF-α) and WBC concentra-
tions. Collectively these findings suggest that the benefits
of physical activity, and particularly MVPA, on inflamma-
tory status may be maintained, and perhaps even more
evident, among individuals with metabolic perturbations.
Limited data on the relationship between objectively
measured physical activity and inflammatory markers in
adults, particularly those at increased cardiometabolic
risk such as obese and insulin resistant individuals, are
available. While the effects of replacing sedentary time
with physical activity on cardiovascular risk biomarkers
are now emerging [19], no data in relation to impact of
substituting sedentary behaviour with different categor-
ies of activity on inflammatory markers exist. Therefore
our primary aim was to determine the relationship be-
tween objectively measured physical activity intensity
and duration with a range of inflammatory markers in-
cluding acute-phase reactants, adipocytokines, pro-
inflammatory cytokines and WBC counts measured at
baseline in a cross-sectional sample of middle-aged
adults, and specifically to investigate whether theoretical
displacement of sedentary time with light activity or
MVPA modulates inflammatory status among all sub-
jects and those at increased cardiometabolic risk (i.e.
obese and insulin resistant individuals).
Methods
Study design and subject recruitment
The Cork and Kerry Diabetes and Heart Disease Study
(Phase II) was a single centre, cross-sectional study con-
ducted between 2010 and 2011. A population represen-
tative random sample (Mitchelstown cohort) was
recruited from a large primary care centre (Livinghealth
Clinic) in Mitchelstown, County Cork, Ireland. Full de-
tails have been published elsewhere [20], but in brief
Mitchelstown cohort participants were randomly se-
lected from all registered attending patients in the 50–
69 year age group. In total 3807 potential participants
were selected from the practice list. Following exclusion
of duplicates, deaths and ineligibles, 3043 were invited
to participate in the study and of these 2047 (49.2%
male) completed the questionnaire and physical exam-
ination components of the baseline assessment (re-
sponse rate 67%). Of the 745 cohort participants
invited to wear the accelerometer 475 subjects agreed
to participate (response rate 64%). Ethics committee ap-
proval conforming to the Declaration of Helsinki was
obtained from the Clinical Research Ethics Committee
of University College Cork. All participants provided
written informed consent.
Accelerometer protocol
Objective physical activity levels were assessed using a
GENEActiv accelerometer (ActivInsights Ltd., Cambridge-
shire, United Kingdom). The technical reliability and val-
idity of this accelerometer has been previously reported
[21]. The tri-axial STMicroelectronics accelerometer with
a dynamic range of +/−6 g (1 g = 9.81 m/s2) was attached
to the participants’ preferred wrist with a strap [22]. Ac-
celeration was sampled at 100 Hz and the accelerometer
worn for 7-consecutive days. Following return of the ac-
celerometer to the co-ordination centre data were ex-
tracted using GENEActiv software and then collapsed
using sum of the vector magnitude (∑|√x2 + y2 + z2 - g|)
into 60s epochs [21]. Each time interval, from the daytime
wear-time (6 am-12 am) periods, was categorized as sed-
entary behaviour, light, moderate and vigorous activity
and MVPA based on validated cut-off points for dominant
and non-dominant wrist wear [23]. Of the 475 study par-
ticipants 14 individuals had no data collected due to
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technical issues or non-return of the device and two
were excluded based on location of wear i.e. leg. Fol-
lowing further exclusion of 63 participants with <10 h
activity on any day, the remaining 396 subjects were
included in the analysis.
Clinical and anthropometric data
All participants attended the clinic in the morning after
an overnight fast (minimum 8 h). Fasting blood samples
were taken on arrival. Participants then completed a Gen-
eral Health Questionnaire and Food Frequency Question-
naire. Data on age, gender and lifestyle factors were
gathered. Smoking status was defined as never, former
and current smokers. Alcohol consumption included
questions regards past and current intake to define mod-
erate and non-moderate drinkers. Anthropometric mea-
surements were recorded with calibrated instruments
according to a standardized protocol. Body weight was
measured in kilograms without shoes, to the nearest
100 g, using a Tanita WB100MA weighing scales (Tanita
Corporation, IL, USA). Height was measured in centi-
metres to 1 decimal place using a Seca Leicester height
gauge (Seca, Birmingham, UK). BMI was calculated. Waist
circumference (defined as mid-way between lowest rib
and iliac crest) was measured in centimetres to 1 decimal
place using a Seca 200 measuring tape (Seca, Birmingham,
UK). The average of two measures was used for analyses.
Biological analyses
Plasma and serum were prepared from fasting blood
samples. Fasting plasma glucose (FPG) was measured by
Cork University Hospital Biochemistry Laboratory using
fresh blood samples using a glucose hexokinase assay.
Serum insulin, CRP, TNF-α, IL-6, adiponectin (ACDC),
leptin, resistin and plasminogen activator inhibitor-1
(PAI-1) were determined using a biochip array system
(Evidence Investigator; Randox Laboratories, Antrim,
UK). C3 was determined by immunoturbidimetric assay
(Rx Daytona; Randox Laboratories, Antrim, UK). WBC
counts were determined by flow cytometry technology
as part of a full blood count by the Cork University Hos-
pital Haematology Laboratory. Homeostasis model as-
sessment (HOMA), a measure of insulin resistance, was
calculated as [(fasting plasma glucose x fasting serum in-
sulin)/ 22.5] [24].
Statistical analysis
Statistical analysis was conducted using PASW Statistics
version 18.0 for Windows (SPSS Inc., Chicago, IL) and
Stata (version 12, Stata Corp, College Station, Texas,
USA). Individual median and 25th and 75th percentiles
for average daily minutes spent in each activity category
and inflammatory markers were calculated. ANOVA, t-
tests and non-parametric tests were used to compare
mean, % and median values, respectively, where appro-
priate. Two different linear regression models (single
and isotemporal) were used. Single model analysis exam-
ined each activity intensity of sedentary behaviour, light
activity and MVPA independently while isotemporal
analyses examined each activity intensity while adjusting
for time in other physical behaviours and total time.
More specifically, the coefficient from an isotemperol
model represents the estimated effects of substituting a
specific activity intensity for the category dropped while
holding total (wear) time and other activity constant
[25]. Thus if we examine the effect of replacing seden-
tary behaviour with light activity we include light activ-
ity, MVPA and total wear time in the model whereas a
model examining the effects of replacing MVPA with
sedentary behaviour would include sedentary behaviour,
light activity and total time. The isotemporal model is a
linear regression model. While its primary function here
is to determine whether substitution of different behav-
iours is beneficial to health it also examines whether this
substitution relationship is linear. Thus the coefficients
represent the effects for every 30-min increase substitu-
tion on each inflammatory marker. These models are de-
scribed in greater detail elsewhere [26, 27]. Prior to entry
into the models all intensity categories were divided by a
constant of 30 such that a unit increase in the activity vari-
able represented a 30 min increase in the given activity in-
tensity. Three models were run for each inflammatory
marker. The first model included age and gender. The sec-
ond model additionally included smoking status, alcohol
and energy intake. The third model additionally adjusted
for BMI and anti-inflammatory medication use. An alpha
level of 0.05 was set to evaluate significance.
Results
Inflammatory and physical activity profiles of the study
sample and subgroups
A total of 396 male and female subjects were included in
the analysis. Characteristics and inflammatory and phys-
ical activity profiles of the study sample and subgroups are
presented in Table 1. The obese individuals had larger
waist circumference, were more insulin resistant, com-
prised slightly less male subjects and had unfavourable in-
flammatory profiles characterized by higher C3, CRP, IL-6,
leptin, resistin, PAI-1 and WBC, and lower ACDC con-
centrations (P < 0.05). Although there was a trend towards
increasing TNF-α concentrations with increasing BMI this
did not reach statistical significance. The insulin resistant
individuals displayed greater BMI and waist circumfer-
ence, comprised more males and in addition to all of the
pro-inflammatory and pro-thrombotic alterations ob-
served in the obese subjects, TNF-α concentrations were
also elevated. No differences in age were noted between
any groups. Average daily duration of sedentary behaviour,
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light activity and MVPA were significantly different within
subgroups (P < 0.05). Obese and insulin-resistant individ-
uals had higher sedentary behaviour and lower physical
activity levels compared to non-obese and non-insulin re-
sistant individuals.
Modulation of inflammatory status by physical activity
intensity and duration
Table 2 presents the inflammatory profiles of the cohort
according to tertiles of sedentary behaviour and physical
activity intensity. Among all subjects increasing time spent
in sedentary behaviour was associated with a more pro-
inflammatory profile characterized by higher concentra-
tions of C3, CRP, IL-6, TNF-α, leptin and WBC (P < 0.05).
In contrast, lower C3, IL6 and leptin concentrations and
lower WBC counts were noted with increasing levels of
light activity (P < 0.05). Greater MVPA duration was asso-
ciated with widespread favourable alterations to the
inflammatory profile, most notably reduced levels of C3,
CRP, IL-6, leptin and WBC (P < 0.05).
Replacing sedentary behaviour with physical activity:
Impact on inflammatory profile
Results from the isotemporal substitution modelling
analyses are presented in Table 3. Reallocating time to
MVPA from sedentary behaviour was linearly associated
with beneficial modifications to the inflammatory profile.
Adjusted for age and gender, more favourable C3, WBC,
IL-6 and leptin concentrations were observed when
30 min of sedentary behaviour was substituted for
30 min of MVPA (B = −3.59; 95% CI, −5.40, −1.78,
B = −0.30; 95% CI, −0.43, −0.16, B = −0.32; 95% CI,
−0.53, −0.11 and B = −0.24; 95% CI, −0.43, −0.05) for
C3, WBC, IL-6 and leptin concentrations, respectively.
All of these associations remained significant in the fur-
ther adjusted models, with the exception of leptin. No
statistically significant associations were observed when
Table 1 Characteristics and inflammatory and physical activity profiles of the study sample and subgroups
Entire sample Normal weight Overweight Obese P Non-insulin
resistant
Insulin resistant P
n 396 79 189 128 293 97
Age (years) 59.58 ± 5.46 58.51 ± 5.43 59.73 ± 5.45 59.58 ± 5.43 0.13 59.49 ± 5.48 59.83 ± 5.44 0.61
Male (%) 46 64.6 54.5 46.9 0.046 41.7 56.7 0.01
BMI (kg/m2) 28.86 ± 4.55 23.25 ± 1.54 27.77 ± 1.35 33.95 ± 3.61 0.000 27.54 ± 3.61 32.85 ± 4.86 0.000
Waist (cm) 96.27 ± 13.39 82.80 ± 8.24 93.51 ± 0.00 108.70 ± 10.85 0.000 92.56 ± 12.04 107.29 ± 11.29 0.000
HOMA-IR 2.96 ± 3.25 1.49 ± 0.95 2.14 ± 1.50 5.11 ± 4.72 0.000 1.68 ± 0.80 6.87 ± 4.56 0.000
Inflammatory profiles
C3 (mg/dL) 136.40 (120.30,
152.09)
115.68 (108.12,
138.27)
134.72 (121.63,
149.40)
147.60 (132.70,
166.90)
0.000 130.89 (115.87,
145.20)
152.52
(137.23,173.53)
0.000
CRP (ng/
mL)
1.35 (0.99, 2.36) 1.02 (0.78, 1.55) 1.34 (1.03, 2.21) 1.68 (1.10, 3.06) 0.000 1.29 (0.97, 1.90) 1.95 (1.16, 3.34) 0.000
IL-6 (pg/mL) 1.78 (1.19, 2.97) 1.30 (0.90, 2.06)) 1.67 (1.13, 2.62) 2.42 (1.63, 3.76) 0.000 1.53 (1.09, 2.53) 2.54 (1.69, 3.78) 0.000
TNF(pg/mL) 5.86 (4.73, 7.18) 5.67 (4.40, 7.10) 5.79 (4.67, 7.04) 6.05 (4.94, 7.82) 0.140 5.55 (4.59, 6.80) 6.89 (5.66, 8.65) 0.000
Leptin (ng/
mL)
2.03 (1.25, 3.16) 1.38 (0.75, 2.00) 2.00 (1.14, 2.75) 3.01 (1.90, 4.87) 0.000 1.89 (1.14, 2.74) 2.78 (1.55,4.92) 0.001
ACDC (ng/
mL)
4.86 (2.86, 7.54) 7.46 (3.89, 10.27) 5.03 (3.17, 7.65) 3.80 (2.45, 5.81) 0.000 5.48 (3.43, 8.24) 3.20 (2.25, 4.73) 0.000
Resistin (ng/
mL)
4.95 (3.85, 6.54) 4.66 (3.68, 5.79) 4.85 (3.87, 6.55) 5.20 (3.99, 6.94) 0.019 4.79 (3.71, 6.31) 5.49 (4.39, 7.61) 0.007
PAI-1 (ng/
mL)
25.53 (18.68,
33.31)
21.80 (16.13,
29.69)
24.27 (18.60,
33.34)
28.55 (19.98,
37.67)
0.005 23.24 (17.35,
31.17)
31.76 (24.49,
40.16)
0.000
WBC (109/L) 5.60 (4.80, 6.70) 5.30 (4.40, 6.40) 5.50 (4.80, 6.50) 6.00 (5.30, 7.50) 0.011 4.60 (5.50, 6.50) 6.30 (5.40, 7.50) 0.000
Physical activity (mins per week)
Sedentary 909 (853, 971) 894 (844, 970) 905 (843, 951) 945 (879, 991) 0.003 898 (840, 957) 952 (891, 994) <0.0001
Light 103 (69, 135) 107 (68, 134) 108 (78, 138) 91 (58, 127) 0.04 109 (75, 141) 85 (55, 119) 0.0001
MVPA 62 (32, 103) 70 (42, 110) 67 (38, 104) 45 (23, 80) 0.0008 69 (38, 107) 45 (22, 68) 0.0001
Values are presented as mean ± S.D., %, and median (25th, 75th percentiles). ANOVA, t-tests and non-parametric tests were used to compare mean, % and median
values, respectively, in subgroups according to BMI and HOMA-IR cut-offs. ACDC adiponectin, C3 Complement component C3, CRP C reactive protein, IL6 interleukin 6,
PAI-1 plasminogen activator inhibitor-1, TNF-α tumour necrosis factor α, WBC White blood cell
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30 min of sedentary behaviour was substituted for light
activity (P > 0.05).
Reallocating sedentary time with physical activity among
high cardiometabolic risk groups
When stratified by BMI, replacing 30 min of sedentary be-
haviour with 30 min of MVPA was linearly associated with
beneficial alterations to WBC counts among the obese
(B = −0.51; 95% CI, −0.91 to − 0.10, P < 0.05) and non-
obese subjects (B = −0.21; 95% CI, −0.32, −0.08) which
remained significant in the fully adjusted model. Further
positive associations with C3 (B = −3.05; 95% CI, −5.09,
−1.03) and IL-6 (B = −0.15; 95% CI, −0.30, −0.0007) con-
centrations were observed among the non-obese subjects
(Table 4). These associations remained significant in all
models. When stratified by HOMA-IR, more favourable
concentrations of C3 (B = −2.43; 95% CI, −4.26 to − 0.60),
IL-6 (B = −0.28; 95% CI, −0.42 to − 0.14) and WBC
counts (B = −0.22; 95% CI, −0.39 to − 0.04) were identi-
fied among the non-insulin resistant individuals following
substitution of 30 min of sedentary behaviour for 30 min
of MVPA (Table 5). These associations remained signifi-
cant in all models. No significant findings were observed
among the insulin resistant individuals (P > 0.05).
Discussion
In this study, we demonstrated that increasing amounts
of sedentary behaviour were associated with unfavour-
able alterations to the inflammatory profile among all
subjects. Conversely increasing levels of light activity,
and to a greater extent increasing MVPA, was associated
with numerous beneficial modifications. Moreover, inde-
pendent of potential confounders and time spent in
other activities, replacing sedentary behaviour with
MVPA among middle-aged adults was associated with a
more favourable inflammatory profile characterized by
lower C3, leptin, IL-6 and WBC concentrations.
Several possible mechanisms may explain the anti-
inflammatory influence of physical activity, including reduc-
tion in visceral fat, enhanced insulin signalling and glucose
transport with subsequent improved insulin sensitivity,
increased expression of anti-inflammatory molecules and
reduced toll-like receptor expression with subsequent de-
creased pro-inflammatory response [28–30]. The reported
anti-inflammatory effects of physical activity have been
largely based on self-reported physical activity and using
CRP as a proxy for inflammatory status [2, 31–35]. Rela-
tively little is known about the influence of both the inten-
sity and duration of objectively measured physical activity
on a range of inflammatory markers in middle-aged males
and females, particularly among individuals at high risk of
developing cardiometabolic disease. Recent examination of
elderly men (mean age 78 years) from the British Regional
Heart Study demonstrated more favourable IL-6 and CRP
concentrations among those with higher levels of total
physical activity, MVPA and light activity [36]. A novel
finding in our study was that C3 concentrations were
positively associated with increasing sedentary behav-
iour and negatively associated with increasing MVPA.
Elevated circulating concentrations of C3, an acute-
phase response protein with a central role in the innate
immune system, have been associated with obesity and
Table 4 Association between sedentary behaviour and physical activity intensity with selected inflammatory markers among non-obese
subjects (n = 268)
C3 (nmol/L) WBC (109/L) IL-6 (pg/mL)
β coefficients (95% CI) Beta β coefficients (95% CI) Beta β coefficients (95% CI) Beta
Model A
Sedentary (mins/day) REPLACED REPLACED REPLACED
Light (mins/day) 0.54 (−1.87, 2.94) 0.03 −0.07 (−0.22, 0.08) −0.07 0.12 (−0.05, 0.30) 0.11
MVPA (mins/day) −3.05 (−5.09, −1.03) ** −0.24 −0.20 (−0.32, −0.08) ** −0.25 −0.15 (−0.30, −0.007) * −0.16
Model B
Sedentary (mins/day) REPLACED REPLACED REPLACED
Light (mins/day) 1.68 (−1.65, 5.02) 0.11 0.07 (−0.13, 0.27) 0.06 0.35 (0.09, 0.62) * 0.28
MVPA (mins/day) −4.72 (−7.80, −1.63)** −031 −0.24 (−0.43, −0.06) * −0.26 −0.31 (−0.56, −0.06) * −0.26
Model C
Sedentary (mins/day) REPLACED REPLACED REPLACED
Light (mins/day) 1.67 (−1.69, 5.02) 0.10 0.07 (−0.13, 0.27) 0.07 0.34 (0.08, 0.61) * 0.26
MVPA (mins/day) −4.69 (−7.83, −1.56) ** −0.32 −0.25 (−0.44, −0.06) * −0.26 −0.30 (−0.55, −0.05) * −0.25
Data are ß coefficients (95% CI) and beta values. C3 Complement component C3, IL6 interleukin 6, WBC White blood cell. Coefficients are based on average daily
sedentary and physical activity duration. Results were expressed as regression coefficients that represented the change in outcome observed when 30 min of
sedentary behaviour was substituted with 30 min of an alternative activity intensity (light activity or MVPA). Model A adjusted for age, gender and alternative
physical behaviour intensities. Model B additionally adjusted for dietary intake, smoking status and alcohol consumption. Model C additionally adjusted for anti-inflammatory
medication. * represents P < 0.05 and ** represents P < 0.01, *** represents P < 0.0001
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increased cardiometabolic risk [37]. We have reported
novel genetic associations between C3 polymorphisms
with metabolic syndrome (MetS) risk [38] and that ab-
dominal obesity and dietary fat modulate the relation-
ship between elevated plasma C3 concentrations, C3
genotype and MetS risk [39]. Although the relationship
between C3 concentrations and cardiometabolic health
has been examined, this has not been yet been investi-
gated in the context of sedentary behaviour and phys-
ical activity in adults. The observed decreases in C3
levels with increasing MVPA (10%) and decreasing sed-
entary time (12%) are similar to the differences re-
ported in incident ischemic event cases and non-cases
[40], and in smokers with and without coronary heart
disease (CHD) [41]. Similarly the differences observed
in IL-6 levels with increasing light activity and MVPA
(14 and 31% respectively) and decreasing sedentary
time (31%) were greater than those reported between
non-cases and cases of CVD and T2DM in the Caer-
philly study [42], and between survivors of a first myo-
cardial infarction and age and gender matched controls
[43] for MVPA alone. Furthermore the differences in
WBC levels comparing top and bottom tertiles of sed-
entary time, light activity, MVPA (16, 18 and 13% re-
spectively) in the current work were greater than those
reported between non-cases and cases of CVD [42].
Collectively these data suggest both physiologically and
clinically significant changes in C3, IL-6 and WBC con-
centrations. To our knowledge the only examinations
of C3 concentrations and objectively measured physical
activity to date have been conducted in children and
adolescents. Exercise, but not total physical activity,
was related to C3 and CRP levels in 9 year old children
[44], whereas total, vigorous and MVPA were not inde-
pendently associated with C3 and CRP levels among
adolescents [45]. In the HELENA study objectively, but
not subjectively, measured vigorous physical activity
was inversely associated with C3 levels in adolescents
[46], highlighting the importance of more accurate ob-
jective measurement of habitual physical activity and
well designed randomised clinical trials to assess the
translation of such cross-sectional observational data to
the clinical setting.
Isotemporal substitution modelling allows examination
of the potential impact of reallocating a certain amount
of time spent in sedentary behaviour with the equivalent
amount of time spent in different physical activity cat-
egories, while keeping total time constant (e.g replacing
30 min sedentary time with 30 min MVPA). Although
usually applied to cross-sectional data the causality cav-
eat applies, however unlike standard regression models
interpretation of the findings is more easily translatable
in terms of the public health message and thus this
methodology is becoming increasingly popular. Benefi-
cial health effects of replacing prolonged sedentary time
with MVPA have been reported. In an examination of
445 healthy men from the Whitehall II epidemiological
cohort Hamer et al., determined the impact of replacing
10 min sedentary time (determined by waist worn accel-
erometer) with light activity and MVPA on HDL-C, try-
glycerides, HbA1c and BMI [47]. Only MVPA was
associated with favourable alterations for all markers. In
Table 5 Association between sedentary behaviour and physical activity intensity with selected inflammatory markers among non-insulin
resistant subjects (n = 293)
C3 (nmol/L) WBC (nmol/L) IL-6 (pg/mL)
β coefficients (95% CI) Beta β coefficients (95% CI) Beta β coefficients (95% CI) Beta
Model A
Sedentary (mins/day) REPLACED REPLACED REPLACED
Light (mins/day) 0.98 (−1.13, 3.10) 0.07 0.15 (−0.01, 0.32) 0.14 0.18 (−0.02, 0.39) 0.13
MVPA (mins/day) −2.43 (−4.26,-0.60) ** −0.20 −0.28 (−0.42, −0.14) *** −0.29 −0.22 (−0.39, −0.04) * −0.19
Model B
Sedentary (mins/day) REPLACED REPLACED REPLACED
Light (mins/day) 1.98 (−0.95, 4.91) 0.13 0.15 (−0.02, 0.32) 0.15 0.31 (0.04, 0.58) * 0.23
MVPA (mins/day) −3.48 (−6.22, −0.75)* −0.26 −0.25 (−0.40, −0.09) ** −0.30 −0.32 (−0.57, −0.06) * −0.25
Model C
Sedentary (mins/day) REPLACED REPLACED REPLACED
Light (mins/day) 2.10 (−0.85, 5.05) 0.14 0.15 (−0.02, 0.32) 0.16 0.32 (0.04, 0.59) * 0.22
MVPA (mins/day) −3.61 (−6.36, −0.85) * −0.27 −0.25 (−0.41, −0.09) ** −0.30 −0.32 (−0.58, −0.06) * −0.26
Data are ß coefficients (95% CI) and beta values. C3 Complement component C3, IL6 interleukin 6, WBC White blood cell. Coefficients are based on average daily
sedentary and physical activity duration. Results were expressed as regression coefficients that represented the change in outcome observed when 30 min of
sedentary behaviour was substituted with 30 min of an alternative activity intensity (light activity or MVPA). Model A adjusted for age, gender and alternative
physical behaviour intensities. Model B additionally adjusted for dietary intake, smoking status and alcohol consumption. Model C additionally adjusted for BMI
and anti-inflammatory medication. * represents P < 0.05 and ** represents P < 0.01, *** represents P < 0.0001
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a cross-sectional Swedish study of 836 middle-aged par-
ticipants (52% women), progressively lower odds ratios
for MetS risk were observed when replacing 10 min of
sedentary time (determined by a hip worn accelerom-
eter) with the same amount of light, moderate and vigor-
ous activity (odds ratio (OR) 0.96 (95% confidence
interval 0.93, 0.98, OR 0.89 (0.82, 0.97) and OR 0.41
(0.26, 0.66), respectively [48]. Buman et al., recently re-
ported beneficial associations with replacing 30 min/day
sedentary time with light activity (improvements in tri-
glyceride and insulin concentrations) and especially with
MVPA (improvements to waist circumference, HDL-C,
triglyceride, glucose and insulin concentrations and in-
sulin sensitivity among a subsample (n = 923) from the
cross-sectional 2005-2006 US NHANES [19]. Isotem-
poral substitution modelling has also recently been ap-
plied to longitudinal data. Using follow-up (mean
4.2 years) data from the 45 and Up study (n = 201, 129)
Stamatakis et al., examined the impact of replacing 1 h
of sedentary behaviour (sitting, television/computer
screen time combined) with a range of activities (sleep-
ing, standing, walking and MVPA) [49]. They reported
lowest mortality risk with replacement of sedentary time
with walking and MVPA. Consistent with these findings
Schmid et al., recently reported a 50% mortality risk re-
duction associated with reallocating 30 min of sedentary
time with equal amount of MVPA [50]. Although some
of these studies examined traditional CVD risk bio-
markers, no study to date has investigated the impact of
reallocating sedentary behaviour with physical activity
on inflammatory markers. Importantly we show here for
the first time that replacing 30 min of sedentary behav-
iour with MVPA is associated with significant reductions
in C3 levels, as well as more favourable leptin, IL-6 and
WBC concentrations in middle-aged adults. Collectively
these data suggest that MVPA may be a potent health
promoter. Indeed it is possible that such a favourable in-
fluence on inflammatory profiles may underlie some of
the previously mentioned associations with cardiometa-
bolic and mortality risk [48–50].
Insulin resistance and obesity are characterized by a
low-grade but chronic inflammatory state, with elevated
circulating levels of CRP, TNF-α, IL-6 and leptin and re-
duced ACDC concentrations associated with increased
cardiometabolic risk [15, 51]. The pathway from obesity
and insulin resistance towards overt T2DM represents a
progressive phenotype, with raised inflammatory status
frequently preceding T2DM by many years. Thus inter-
ventions to improve inflammatory status may attenuate
progression from obesity and insulin resistance towards
overt T2DM. Data from the NHANES demonstrated an
inverse association between accelerometer derived ob-
jectively measured MVPA and CRP levels among dia-
betic adults [13]. In pre-diabetic adults increasing total
and leisure time physical activity was associated with re-
duced IL-6 and increased ACDC concentrations [52].
Jennersjo et al., also demonstrated a negative association
between IL-6 and CRP concentrations and daily number
of steps recorded by pedometer in middle-aged adults
with T2DM, with the greatest reductions observed
among those achieving the recommended 10,000 steps a
day [53]. In the current work objective measurement of
physical activity over a 7-day period revealed a trend to-
wards increased sedentary time and less time engaged in
MVPA among the high cardiometabolic risk individuals.
Although they displayed the most unfavourable inflam-
matory profiles, the isotemporal substitution analysis
only identified a positive association between replacing
sedentary behaviour with MVPA on WBC counts among
the obese subjects, whereas substituting sedentary be-
haviour with MVPA was associated with reduced levels
of C3, IL-6 and WBCs in both the non-obese and non-
insulin resistant subjects. It may be that given the
greater amount of time spent in sedentary behaviour
among the high risk groups that a greater amount of
sedentary time (> 30 min) needs to be displaced in order
to see an impact on these inflammatory biomarkers
among obese and insulin resistant individuals. These
findings are consistent with the concept that sedentary
behaviour is distinct from lack of MVPA (and vice versa)
and has independent and different associations with
metabolic health outcomes and thus should be treated
as a separate entity [54]. Further research focussed on
high cardiometabolic risk groups is warranted.
The main strengths of our study are the characterisa-
tion of the largest range of inflammatory markers exam-
ined in the context of sedentary behaviour, physical
activity and isotemporal substitution analysis. Further-
more these biomarkers were determined at a commer-
cial laboratory ensuring a high level of reproducibility.
Secondly we used a valid and reliable accelerometer cap-
able of objectively assessing time spent in sedentary,
light, moderate and vigorous activity categories [21, 55].
In addition, this accelerometer collects data as raw ac-
celeration and stores the data as g units for offline ana-
lysis. This allows efficient data cleaning, spurious data
management, and application of various data processing
algorithms post-data collection thereby increasing the
transparency of the data and permitting more informed
interpretation of the results. Notwithstanding these
strengths some limitations can be identified. The cross-
sectional study design limits inference regards causality
and although we controlled for confounding factors we
cannot exclude the possibility that unmeasured
confounders such as genotype may also influence our
observations. Physical activity data were collected over a
one-week period which may not reflect habitual physical
activity levels over a longer time period. Compared with
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self-report, objective measurement of physical activity
using accelerometers is more precise and less biased
(particularly with respect to recall and social desirability
bias) with reduced potential for measurement error and
misclassification bias. However potential sources of bias
such as reactivity and social desirability, which may
cause the accelerometer wearer to change their usual
physical activity level, may still remain. The stratification
of analysis by subgroups resulted in small sample sizes,
thus sub-group analyses may not have had sufficient
power to determine true associations between physical
behaviour and inflammatory status. Generalizability of
our findings may also be limited. The Mitchelstown co-
hort (response rate 67%) was a random sample of
middle-aged adults from an area representative of both
urban and rural population in Ireland. Our previous re-
search suggests that approximately 98% of Irish adults
are registered with a GP and that, even in the absence of
a universal patient registration system, it is possible to
perform population based epidemiological studies that
are representative of the general population using these
methods [56]. Within the sub-sample examined in the
current analysis women were more likely to agree to
wear the accelerometer. However it should be noted that
there were no statistically significant differences in age,
gender or BMI between all subjects included (n = 398)
and excluded (n = 77) in the final analysis.
Conclusions
Among middle-aged adults sampled from primary care,
increasing amounts of objectively measured physical ac-
tivity (light activity and particularly MVPA) showed
favourable associations and sedentary behaviour detri-
mental associations with a range of inflammatory bio-
markers. Furthermore our results provide evidence that
replacing sedentary behaviour with MVPA is associated
with beneficial modifications to the inflammatory profile,
suggesting that MVPA may be an important potential
modifier of adverse inflammatory profiles. These find-
ings represent an important contribution to the know-
ledge base and warrant further investigation. They
provide justification for the design of randomized trials
aimed at replacing a portion of sedentary behaviour with
physical activity which will help generate evidence to
guide policy in this field.
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